TG Therapeutics, Inc.
TGTXFigures shown here come from public SEC filings. Dates beside each section show the available history.
How TG Therapeutics, Inc. Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Source: TG Therapeutics, Inc. — 10-K filed Feb 27, 2026
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 15 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 15, 2026.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among TG Therapeutics, Inc.'s recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2024-01-03 · Power Sean A: Larger than 16 of the 17 other insider sales of Common Stock on file. SEC filing
- 2023-06-02 · Power Sean A: Larger than 25 of the 27 other insider sales of COMMON STOCK on file. SEC filing
- 2022-01-04 · Power Sean A: Larger than 26 of the 27 other insider sales of COMMON STOCK on file. SEC filing
- 2020-09-09 · RA CAPITAL MANAGEMENT, L.P.: Larger than all 17 other insider sales of Common Stock on file. SEC filing
- 2014-12-16 · WEISS MICHAEL S: Larger than all 27 other insider sales of COMMON STOCK on file. SEC filing
Independent insiders buying near the same time
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2025-11-24 | Echelard Yann · Director | Common Stock | S — Open market or private sale | −5,000 | 32.57 | SEC filing |
| 2025-09-11 | Lonial Sagar · Director | Common Stock | S — Open market or private sale | −20,852 | 32.24 | SEC filing |
| 2025-06-13 | Echelard Yann · Director | Common Stock | S — Open market or private sale | −10,000 | 36.94 | SEC filing |
| 2025-01-06 | Power Sean A · CFO | Common Stock | S — Open market or private sale | −10,021 | 28.53 | SEC filing |
| 2025-01-03 | Power Sean A · CFO | Common Stock | S — Open market or private sale | −11,337 | 30.29 | SEC filing |
| 2024-11-11 | Lonial Sagar · Director | Common Stock | S — Open market or private sale | −5,000 | 30.44 | SEC filing |
| 2024-11-11 | Charney Laurence N · Director | Common Stock | S — Open market or private sale | −25,000 | 30.20 | SEC filing |
| 2024-11-05 | Echelard Yann · Director | Common Stock | S — Open market or private sale | −20,000 | 24.48 | SEC filing |
Showing 8 of 20 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-11 | Charney Laurence N · Director | Stock Tracking Unit | A — Grant, award, or other acquisition | +8,325 | SEC filing |
| 2026-06-11 | Hoberman Kenneth · Director | Stock Tracking Unit | A — Grant, award, or other acquisition | +8,325 | SEC filing |
| 2026-06-11 | Echelard Yann · Director | Stock Tracking Unit | A — Grant, award, or other acquisition | +8,325 | SEC filing |
| 2026-06-11 | HUME DANIEL · Director | Stock Tracking Unit | A — Grant, award, or other acquisition | +8,325 | SEC filing |
| 2026-06-11 | Lonial Sagar · Director | Stock Tracking Unit | A — Grant, award, or other acquisition | +8,325 | SEC filing |
| 2026-01-29 | Charney Laurence N · Director | Common Stock | G — Bona fide gift | −13,197 | SEC filing |
| 2026-01-28 | Charney Laurence N · Director | Common Stock | G — Bona fide gift | −30,000 | SEC filing |
| 2026-01-08 | WEISS MICHAEL S · CEO | Common Stock | A — Grant, award, or other acquisition | +622,000 | SEC filing |
Showing 8 of 28 rows
Other activity
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2017-01-01 | WEISS MICHAEL S · CEO and President | Common Stock (Restricted) | D — Disposition to the issuer | −3,381,866 | SEC filing |
| 2010-03-08 | Herskowitz Neil · Director | Common Stock | J — Other acquisition or disposition | +61,663 | SEC filing |
| 2010-03-08 | WEISER MICHAEL · Other | Common Stock | J — Other acquisition or disposition | +44,678 | SEC filing |
| 2010-03-08 | MCINERNEY TIMOTHY · Director | Common Stock | J — Other acquisition or disposition | +6,347 | SEC filing |
Showing 4 of 4 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.